Vasuda Capital Management operates Vasuda Life Sciences Fund, a hedge fund focused on life sciences industry (biotech, pharma, medical devices). The firm's funds have outperformed the S&P 500 in each of last 4 months since inception (up 29%). The firm was founded by Dr. Bhavneesh Sharma, MD, MBA, who is a physician with an MBA in finance and financial markets from the New York University Stern School of Business.

"The biotech industry will see a game-changing transformation in the next 10 years with advances in genomic, regenerative and personalized medicine. The industry is changing the established treatments in areas like immuno-oncology, chronic hepatitis C and fibrotic diseases", said Dr. Sharma. The fund is accepting new investors.